ALDH1A3 and cancer: These data suggest that ALDH1A3-positive cancers are retinoid insensitive and thus ALDH1A3 may either possess a moonlighting function in cancer, such as detoxifying reactive aldehydes or controlling glycolysis flux,22,23 or may generate atRA that acts in a paracrine fashion, as has been more recently described.24